Trial intelligence / Profile preview

Dezocine for Postoperative Delirium in Elderly Cardiac Surgery Patients

NCT07768150Not yet recruiting

Sponsor
Chinese Academy of Medical Sciences
Start
Sep 2026
Primary completion
Dec 2027
Countries
1
01

Overview

Randomised trial of dezocine in postoperative delirium (POD) (2 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Incidence of postoperative delirium at 7 days. Planned start Sep 2026; status: not yet recruiting.

02

Drugs

dezocine
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on NCT07768150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07768150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call